Moreover, the inhibition of circPDSS1 resulted in the decreased expression of GPX4 and GCLC, indicating that the circPDSS1/miR-137/SLC7A11/GPX4/GCLC pathway could be a promising treatment approach for NSCLC. This evidence concerns the gene GPX4 and non-small cell lung carcinoma.